Cover Image
市場調查報告書

切片設備的全球市場 2022年:核心針切片檢查、吸引切片檢查、真空輔助下切片檢查

Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 544254
出版日期 內容資訊 英文 221 Pages
訂單完成後即時交付
價格
Back to Top
切片設備的全球市場 2022年:核心針切片檢查、吸引切片檢查、真空輔助下切片檢查 Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022
出版日期: 2017年08月16日 內容資訊: 英文 221 Pages
簡介

全球切片設備市場,在預測期間內預計以6.8%的年複合成長率 (CAGR) 擴大,從2017年的17億4,000萬美元到2022年達到24億2,000萬美元。癌症患者數大幅增加,微創切片檢查數的增加,及各國的政府 & 全球保健機關的各種舉措,成為在預測期間內對切片設備市場成長貢獻的主要原因。可是,導致產品召回的切片設備相關的患者安全風險及切片檢查治療相關感染疾病風險等要素,預計某種程度抑制該市場的成長。

本報告以全球切片設備市場為研究主題,提供市場概要,市場發展促進、阻礙因素,市場上課題及機會,各產品、應用、誘導技術、終端用戶、地區的市場現況與展望相關調查分析,競爭環境,主要企業簡介彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 切片設備:市場概要
  • 切片設備市場:已開發國家 vs. 新興國家
  • 地區概要:切片設備市場
  • 切片設備市場:各產品
  • 切片設備市場:地區混合

第5章 市場概要

  • 主要市場動態
    • 市場成長的促進要素
    • 市場成長的阻礙因素
    • 市場機會
    • 市場課題
  • 產業趨勢
    • 液態切片的登場
    • 完全整合型切片設備的開發
  • 法規分析
    • 北美
    • 歐洲
    • 亞太地區 (APAC)
    • 南美

第6章 全球切片設備市場:各產品

  • 簡介
  • 針為基礎的切片設備
    • 核心切片設備
    • 吸引切片穿刺針
    • 真空輔助下切片設備
  • 治療用托盤
  • 定位線
  • 其他產品

第7章 全球切片設備市場:各應用領域

  • 簡介
  • 乳房切片
  • 肺切片檢查
  • 大腸切片檢查
  • 前列腺切片檢查
  • 其他應用

第8章 全球切片設備市場:各誘導技術

  • 簡介
  • 超音波誘導下切片檢查
  • 定位誘導下切片檢查
  • MRI誘導下切片檢查
  • 其他誘導技術

第9章 全球切片設備市場:各終端用戶

  • 簡介
  • 醫院
  • 大學、研究機關
  • 診斷、影像中心

第10章 切片設備市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 簡介
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭基準

第12章 企業簡介

  • C. R. BARD, INC.
  • BECTON, DICKINSON AND COMPANY
  • COOK GROUP INCORPORATED
  • DEVICOR MEDICAL PRODUCTS, INC. (A PART OF LEICA BIOSYSTEMS)
  • ARGON MEDICAL DEVICES, INC.
  • B. BRAUN MELSUNGEN AG
  • CARDINAL HEALTH, INC.
  • Olympus Corporation
  • BOSTON SCIENTIFIC CORPORATION
  • FUJIFILM HOLDINGS CORPORATION
  • INRAD, INC.
  • MEDTRONIC PLC

第13章 附錄

目錄
Product Code: MD 5504

"The global biopsy devices market is projected to grow at a CAGR of 6.8%."

The global biopsy devices market is projected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% during the forecast period. The significant increase in the number of people who have cancer, growing number minimally invasive biopsies, and government initiatives in various countries & global health organizations are the major factors responsible for the growth of the biopsy devices market during the forecast period. However, factors such as patient safety risks associated with biopsy devices leading to product recalls and risk of infections related to biopsy procedures are expected to hinder the growth of this market to a certain extent.

"The needle-based biopsy instruments segment is expected to grow at the fastest rate during the forecast period."

By product, the global biopsy devices market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and other products such as forceps, markers, probes, punches, curettes, and sutures. The needle-based biopsy instruments segment is expected to register the highest CAGR during the forecast period owing to increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.

"The breast biopsy segment dominated the biopsy devices market in 2016."

On the basis of application, the biopsy devices market is segmented into breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others. In 2016, the breast biopsy segment accounted for the major share of the global biopsy devices market. This is primarily due to the rising prevalence of breast cancer and growing awareness of the disease.

"Stereotactic-guided biopsy segment to witness the highest growth during the forecast period."

On the basis of guidance technique, the biopsy devices market is segmented into ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging (MRI)-guided biopsy, and other guidance techniques (positron emission tomography, fluoroscopy, and thermography). The stereotactic-guided segment is expected to register for the highest CAGR during the forecast period. This is primarily due to the advantage of this guidance technique in evaluating even tiny masses which are not visible on ultrasound; moreover, it is a cost-effective procedure as compared to open surgical biopsies and leaves fewer scars with almost no pain.

"APAC to witness the highest growth during the forecast period."

Geographically, the global biopsy devices market is broadly segmented into five major geographies, namely, North America, Europe, Asia-Pacific (APAC), Latin America, and the Middle East & Africa. In 2016, North America commanded a major share of the global biopsy devices market. However, Asia-Pacific is expected to witness the highest growth during the forecast period. The significant growth of the Asia-Pacific market is mainly attributed to the large population in countries like China and India, rising prevalence and awareness of cancer, improving healthcare infrastructure, increasing healthcare spending, increasing per capita income, government initiatives, and rising focus of key market players in the region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-42%, Tier 2-38% and Tier 3-20%
  • By Designation - C-level-40%, Director Level-35%, Others-25%
  • By Region - North America-35%, Europe-30%, Asia-Pacific-20%, RoW-15%

Some of the prominent players in the biopsy devices market include C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).

Research Coverage:

The report analyzes the various types of biopsy devices in the market and their adoption patterns. It aims at estimating the market size and future growth potential of the biopsy devices market for different segments such as product, guidance technique, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies for strengthening their market position.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the biopsy devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the biopsy devices market
  • Market Development: Comprehensive information about lucrative emerging markets by product, guidance technique, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the biopsy devices market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and manufacturing capabilities of leading players in the biopsy devices market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. BIOPSY DEVICES: MARKET OVERVIEW
  • 4.2. BIOPSY DEVICES MARKET: DEVELOPED VS. DEVELOPNIG COUNTRIES
  • 4.3. GEOGRAPHIC SNAPSHOT: BIOPSY DEVICES MARKET (2016)
  • 4.4. BIOPSY DEVICES MARKET, BY PRODUCT (2017 VS. 2022)
  • 4.5. BIOPSY DEVICES MARKET : GEOGRAPHIC MIX

5. MARKET OVERVIEW

  • 5.1. KEY MARKET DYNAMICS
    • 5.1.1. MARKET DRIVERS
      • 5.1.1.1. Rising prevalence of cancer
      • 5.1.1.2. Increasing preference for minimally invasive surgeries
      • 5.1.1.3. Initiatives undertaken by government and global health organizations
      • 5.1.1.4. Improved reimbursement scenario in U.S.
    • 5.1.2. MARKET RESTRAINTS
      • 5.1.2.1. Product recalls
      • 5.1.2.2. Risk of infections
    • 5.1.3. MARKET OPPORTUNITIES
      • 5.1.3.1. Emerging economies
    • 5.1.4. MARKET CHALLENGES
      • 5.1.4.1. Underdeveloped healthcare infrastructure and dearth of resources in developing countries
  • 5.2. INDUSTRY TRENDS
    • 5.2.1. EMERGENCE OF LIQUID BIOPSY
    • 5.2.2. DEVELOPMENT OF FULLY INTEGRATED BIOPSY DEVICES
  • 5.3. REGULATORY ANALYSIS
    • 5.3.1. NORTH AMERICA
      • 5.3.1.1. U.S.
    • 5.3.2. EUROPE
    • 5.3.3. APAC
      • 5.3.3.1. Japan
      • 5.3.3.2. China
      • 5.3.3.3. India
    • 5.3.4. LATIN AMERICA
      • 5.3.4.1. Brazil
      • 5.3.4.2. Mexico
      • 5.3.4.3. Colombia

6. GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. NEEDLE-BASED BIOPSY INSTRUMENTS
    • 6.2.1. CORE BIOPSY DEVICES
    • 6.2.2. ASPIRATION BIOPSY NEEDLES
    • 6.2.3. VACUUM-ASSISTED BIOPSY DEVICES
  • 6.3. PROCEDURE TRAYS
  • 6.4. LOCALIZATION WIRES
  • 6.5. OTHER PRODUCTS

7. GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. BREAST BIOPSY
  • 7.3. LUNG BIOPSY
  • 7.4. COLORECTAL BIOPSY
  • 7.5. PROSTATE BIOPSY
  • 7.6. OTHER APPLICATIONS

8. GLOBAL BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE

  • 8.1. INTRODUCTION
  • 8.2. ULTRASOUND-GUIDED BIOPSY
  • 8.3. STEREOTACTIC-GUIDED BIOPSY
  • 8.4. MRI-GUIDED BIOPSY
  • 8.5. OTHER GUIDANCE TECHNIQUES

9. GLOBAL BIOPSY DEVICES MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. ACADEMIC AND RESEARCH INSTITUTES
  • 9.4. DIAGNOSTIC AND IMAGING CENTERS

10. BIOPSY DEVICES MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC
  • 10.5. LATIN AMERICA
  • 10.6. MIDDLE EAST AND AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1. VISIONARY LEADERS
    • 11.3.2. INNOVATORS
    • 11.3.3. EMERGING COMPANIES
    • 11.3.4. DYNAMIC DIFFERENTIATORS
  • 11.4. COMPETITIVE BENCHMARKING
    • 11.4.1. STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS)
    • 11.4.2. BUSINESS STRATEGYEXCELLENCE (25 PLAYERS)

Top 25 companies analysed for this study are - C. R. Bard, Inc. (U.S.), Cook Group Incorporated (U.S.), Becton, Dickinson and Company (U.S.), Devicor Medical Products, Inc. (Leica) (U.S.), Argon Medical Devices, Inc. (U.S.), INRAD Inc. (U.S.), SOMATEX Medical Technologies GmbH (Germany), Tsunami S.r.l. (Italy), Scion Medical Technologies, LLC (U.S.), UROMED Kurt Drews KG (U.S.), STERYLAB S.r.l. (Italy), DTR Medical Ltd (U.K.), Endomed Systems GmbH (Germany), CONMED Corporation (U.S.), TSK Laboratory Europe B.V. (Netherlands), ZAMAR CARE (Croatia), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Siemens Healthineers (Germany), GE Healthcare (U.K.), Boston Scientific Corporation (U.S.), Fujifilm Holdings Corporation (U.S.), Olympus Corporation (Japan), Gallini S.r.l. (Italy), Medtronic plc (Ireland)

12. COMPANY PROFILES (Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy)*

  • 12.1. C. R. BARD, INC.
  • 12.2. BECTON, DICKINSON AND COMPANY
  • 12.3. COOK GROUP INCORPORATED
  • 12.4. DEVICOR MEDICAL PRODUCTS, INC. (A PART OF LEICA BIOSYSTEMS)
  • 12.5. ARGON MEDICAL DEVICES, INC.
  • 12.6. B. BRAUN MELSUNGEN AG
  • 12.7. CARDINAL HEALTH, INC.
  • 12.8. OLYMPUS CORPORATION
  • 12.9. BOSTON SCIENTIFIC CORPORATION
  • 12.10. FUJIFILM HOLDINGS CORPORATION
  • 12.11. INRAD, INC.
  • 12.12. MEDTRONIC PLC

*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: COMPARISON OF REIMBURSEMENT FOR BIOPSY PROCEDURES, 2015 VS. 2017
  • TABLE 2: REIMBURSEMENT FOR BIOPSY PROCEDURES, 2017
  • TABLE 3: INDICATIVE LIST OF FDA PRODUCT RECALLS FOR BIOPSY DEVICES (2016-2017)
  • TABLE 4: BIOPSY DEVICES UNDER 21 CFR 876.1075 WITH PRODUCT CODES
  • TABLE 5: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
  • TABLE 6: NOMENCLATURE OF APPLICABLE MEDICAL DEVICES WITH CODES
  • TABLE 7: REGULATORY CLASSIFICATION FOR MEDICAL DEVICES IN INDIA
  • TABLE 8: BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
  • TABLE 9: MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10: COLOMBIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 11: GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 12: GLOBAL NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 14: MAJOR BRANDS OF CORE BIOPSY DEVICES
  • TABLE 15: GLOBAL CORE BIOPSY DEVICES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 16: GLOBAL CORE BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL CORE BIOPSY GUNS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 18: GLOBAL CORE BIOPSY NEEDLES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 19: MAJOR BRANDS OF ASPIRATION BIOPSY NEEDLES
  • TABLE 20: GLOBAL ASPIRATION BIOPSY NEEDLES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 21: MAJOR BRANDS OF VACUUM-ASSISTED BIOPSY DEVICES
  • TABLE 22: GLOBAL VACUUM-ASSISTED BIOPSY DEVICES MARKET, REGION/COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 24: GLOBAL VACUUM-ASSISTED BIOPSY SYSTEMS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 25: GLOBAL VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 26: GLOBAL PROCEDURE TRAYS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 27: MAJOR BRANDS OF LOCALIZATION WIRES
  • TABLE 28: GLOBAL LOCALIZATION WIRES MARKET SIZE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 29: GLOBAL OTHER BIOPSY PRODUCTS MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 31: GLOBAL BIOPSY DEVICES MARKET FOR BREAST BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 32: GLOBAL BIOPSY DEVICES MARKET FOR LUNG BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 33: GLOBAL BIOPSY DEVICES MARKET FOR COLORECTAL BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 34: GLOBAL BIOPSY DEVICES MARKET FOR PROSTATE BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 35: GLOBAL BIOPSY DEVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 36: GLOBAL BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 37: GLOBAL BIOPSY DEVICES MARKET FOR ULTRASOUND-GUIDED BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 38: GLOBAL BIOPSY DEVICES MARKET FOR STEREOTACTIC-GUIDED BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 39: GLOBAL BIOPSY DEVICES MARKET FOR MRI-GUIDED BIOPSY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 40: GLOBAL BIOPSY DEVICES MARKET FOR OTHER GUIDANCE TECHNIQUES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 41: GLOBAL BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 42: NUMBER OF HOSPITALS, BY REGION (2010 VS. 2014)
  • TABLE 43: GLOBAL BIOPSY DEVICES MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 44: GLOBAL BIOPSY DEVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 45: GLOBAL BIOPSY DEVICES MARKET FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 46: BIOPSY DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 50: NORTH AMERICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: NORTH AMERICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 53: NORTH AMERICA: BIOPSY DEVICES MARKET, BY GUIDING TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 54: NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 55: ESTIMATED NEW CASES OF CANCER IN 2017
  • TABLE 56: KEY MARKET INDICATORS: U.S.
  • TABLE 57: U.S.: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 58: U.S.: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: U.S.: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 60: U.S.: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: U.S.: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 62: U.S.: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 63: U.S.: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 64: KEY MARKET INDICATORS: CANADA
  • TABLE 65: OVERVIEW OF THE BREAST, CERVICAL, AND COLORECTAL CANCER SCREENING PROGRAMS ACROSS CANADA
  • TABLE 66: CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 67: CANADA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 68: CANADA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: CANADA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: CANADA: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 71: CANADA: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 72: CANADA: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 73: EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 75: EUROPE: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: EUROPE: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: EUROPE: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 79: EUROPE: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 80: EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 81: KEY MARKET INDICATORS: GERMANY
  • TABLE 82: GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 83: GERMANY: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 84: GERMANY: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: GERMANY: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 86: GERMANY: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 87: GERMANY: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 88: GERMANY: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 89: KEY MARKET INDICATORS: FRANCE
  • TABLE 90: FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 91: FRANCE: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: FRANCE: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 93: FRANCE: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 94: FRANCE: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 95: FRANCE: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 96: FRANCE: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 97: KEY MARKET INDICATORS: U.K.
  • TABLE 98: U.K.: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 99: U.K.: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: U.K.: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 101: U.K.: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 102: U.K.: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 103: U.K.: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 104: U.K.: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 105: KEY MARKET INDICATORS: ITALY
  • TABLE 106: ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 107: ITALY: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 108: ITALY: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 109: ITALY: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 110: ITALY: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 111: ITALY: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 112: ITALY: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 113: KEY MARKET INDICATORS: SPAIN
  • TABLE 114: SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 115: SPAIN: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 116: SPAIN: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: SPAIN: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 118: SPAIN: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 119: SPAIN: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 120: SPAIN: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 121: ROE: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 122: ROE: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: ROE: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 124: ROE: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 125: ROE: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 126: ROE: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 127: ROE: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 128: APAC: BIOPSY DEVICES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 129: APAC: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 130: APAC: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 131: APAC: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 132: APAC: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 133: APAC: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 134: APAC: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 135: APAC: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 136: KEY MARKET INDICATORS: JAPAN
  • TABLE 137: JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 138: JAPAN: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 139: JAPAN: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 140: JAPAN: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 141: JAPAN: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 142: JAPAN: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 143: JAPAN: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 144: KEY MARKET INDICATORS: CHINA
  • TABLE 145: CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 146: CHINA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 147: CHINA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 148: CHINA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 149: CHINA: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 150: CHINA: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 151: CHINA: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 152: KEY MARKET INDICATORS: INDIA
  • TABLE 153: INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 154: INDIA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 155: INDIA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 156: INDIA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 157: INDIA: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 158: INDIA: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 159: INDIA: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 160: ROAPAC: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 161: ROAPAC: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 162: ROAPAC: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 163: ROAPAC: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 164: ROAPAC: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 165: ROAPAC: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 166: ROAPAC: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 167: LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 168: LATIN AMERICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 169: LATIN AMERICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 170: LATIN AMERICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 171: LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 172: LATIN AMERICA: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 173: LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 174: MIDDLE EAST AND AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 175: MIDDLE EAST AND AFRICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 176: MIDDLE EAST AND AFRICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 177: MIDDLE EAST AND AFRICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 178: MIDDLE EAST AND AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 179: MIDDLE EAST AND AFRICA: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2015-2022 (USD MILLION)
  • TABLE 180: MIDDLE EAST AND AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: GLOBAL BIOPSY MARKET, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: GLOBAL BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: GLOBAL BIOPSY DEVICES MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: GEOGRAPHIC SNAPSHOT: BIOPSY DEVICES MARKET
  • FIGURE 11: INCREASING PREVALENCE OF CANCER IS THE KEY MARKET DRIVER FOR BIOPSY DEVICES
  • FIGURE 12: DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: U.S. ACCOUNTED FOR THE LARGEST SHARE OF THE BIOPSY DEVICES MARKET IN 2016
  • FIGURE 14: NEEDLE-BASED BIOPSY INSTRUMENTS WILL CONTINUE TO DOMINATE THE BIOPSY DEVICES MARKET IN 2022
  • FIGURE 15: NORTH AMERICA TO DOMINATE THE GLOBAL BIOPSY DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: BIOPSY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: CANCER PREVALENCE AND MORTALITY RATE, BY COUNTRY, 2012
  • FIGURE 18: INCREASING CANCER PREVALENCE IN THE GERIATRIC POPULATION (2012-2030)
  • FIGURE 19: CE MARK APPROVAL PROCESS FOR BIOPSY DEVICES IN EUROPE
  • FIGURE 20: REGULATORY PROCESS FOR MEDICAL DEVICES IN BRAZIL
  • FIGURE 21: REGULATORY PROCESS FOR MEDICAL DEVICES IN MEXICO
  • FIGURE 22: REGULATORY PROCESS FOR MEDICAL DEVICES IN COLOMBIA
  • FIGURE 23: GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 24: BREAST BIOPSY TO DOMINATE THE BIOPSY DEVICES MARKET IN 2017
  • FIGURE 25: ULTRASOUND-GUIDED BIOPSY TO DOMINATE THE BIOPSY DEVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 26: HOSPITALS WILL CONTINUE TO DOMINATE THE BIOPSY DEVICES MARKET IN 2022
  • FIGURE 27: BIOPSY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 28: NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT
  • FIGURE 29: CANADA: CANCER STATISTICS
  • FIGURE 30: EUROPE: BIOPSY DEVICES MARKET SNAPSHOT
  • FIGURE 31: APAC: BIOPSY DEVICES MARKET SNAPSHOT
  • FIGURE 32: GLOBAL BIOPSY DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 33: BIOPSY DEVICES MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017
  • FIGURE 34: C.R. BARD, INC.: COMPANY SNAPSHOT
  • FIGURE 35: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 36: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 37: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 38: CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 39: OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 41: FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 42: MEDTRONIC PLC: COMPANY SNAPSHOT
Back to Top